Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis (vol 14, pg 983, 2024)
Por:
Torres, T, Petersen, AS, Ivens, U, Vilaro, AB, Stinson, J and Carrascosa, JM
Publicada:
1 feb 2025
Ahead of Print:
1 ene 2025
Resumen:
Filiaciones:
Torres, T:
Univ Porto, CHU Santo Antonio, Porto, Portugal
Petersen, AS:
LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark
Ivens, U:
LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark
Vilaro, AB:
LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark
Stinson, J:
LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark
:
UAB, Hosp Univ Germans Trias I Pujol, IGTP, Badalona, Spain
Green Submitted, gold
|